ReviewVox sanguinis2026
Paris Olympics and Paralympics: Insights from nationwide coordination in preparedness, supply chain management and blood inventory.
Review in Vox sanguinis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Paris 2024 Olympic Games posed a unique challenge due to their scale, associated risks and the need for robust healthcare preparedness. This review outlines the forecasting and anticipatory measures taken by the Etablissement français du sang (EFS) to ensure a resilient blood supply chain throughout the event. A steering committee was formed 2 years in advance to coordinate risk assessments, operational planning and institutional collaboration. The EFS aimed to maintain daily reserves of 90,000 red blood cell (RBC) units, anticipating a 25% shortfall in the Île-de-France region, which was to be balanced by increased contributions from other regions. To support operations, logistical strategies involved the prepositioning of supplies, securing transport routes and reinforcing both trauma centres and Olympic venues. Staffing was also adapted, with changes to work schedules, an extended summer leave period and provisions for remote work at EFS headquarters. In anticipation of seasonal infectious risks, nucleic acid testing (NAT) was implemented for West Nile virus (WNV) and dengue (DENV) in high-risk areas. Cybersecurity measures were also reinforced through strengthened information technology infrastructure and integration with the national cyber crisis response system. These proactive measures proved effective: blood stocks remained stable, only a few arboviral infections were detected and no major cyber incidents occurred. The Paris 2024 experience emphasizes the importance of early, coordinated and cross-sectoral planning in safeguarding national blood supplies during mass events. The centralized structure of the EFS, along with its integration into public health systems and past experience with major events, enabled uninterrupted and resilient service delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.